Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,891.00
Bid: 1,887.00
Ask: 1,889.00
Change: 16.00 (0.85%)
Spread: 2.00 (0.106%)
Open: 1,897.00
High: 1,897.00
Low: 1,877.00
Prev. Close: 1,875.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday tips round-up: Hikma, African Barrick, Lenovo

Fri, 17th Aug 2012 06:58

What a difference a year makes, Tempus in The Times proclaims. When the Arab Spring was in full flow, investors worried that Hikma Pharmaceuticals was too exposed to the unstable region. The company, based in Jordan, almost halved last year's sales growth forecast as governments fell. Now it looks well placed to benefit from the region's recovery ? and investors are grateful that it has largely escaped the eurozone crisis, which has seen governments slash healthcare spending. The company is gradually shifting production to the developing world, where costs are cheaper. Analysts say that Hikma has better growth prospects than its European rivals, a view confirmed by yesterday's results. Shares rose five per cent yesterday, but are still off the high reached before the Arab Spring unfolded. Now an Arab Spring premium should apply. Buy, says Tempus.Hold African Barrick Gold (ABG) until the bid situation becomes clear is the advice of Questor in the Daily Telegraph. Two state-owned companies have approached African Barrick Gold's (ABG) parent company Barrick Gold with a view to making an offer for part, or whole, of ABG. Barrick Gold is continuing talks with China National Gold, after it apparently rejected a low-ball bid from Zijin Mining Group. Questor thinks Barrick Gold is more likely to sell a portion of its stake rather than sell out completely. This latest move by China may or may not mark the start of a wave of mergers in gold miners. However, the sector certainly looks ripe for consolidation for companies with the financial muscle to buy quality assets. Questor last said ABG shares were a speculative buy on July 24th when they stood at 317p. They are now 34% above that level and because the bid situation is unclear, the rating is now cut to hold.Chinese companies know all about "zouchuqu" - going out and staking a claim in global markets whatever the cost, observes Lex, as the Financial Times's venerable column takes a look at the world's second largest PC maker, Lenovo. On Thursday, the PC maker said that in the past three months it increased revenues 35% from a year earlier, and widened its paper-thin margins enough to increase operating profit by nearly 50%. Good work, but there is more to be done. While Lenovo's share in the PC market is now just short of global leader Hewlett-Packard's, its operating margins are a quarter of HP's. Progress may take time, though. This month it announced a partnership with EMC, the US storage server group that once worked with Dell. Margins are fatter in the server market, but Lenovo will be up against tough competitors in HP, IBM and Dell, who control three-quarters of it. However, any Chinese company that has proved it can combine global ambition and improving profitability deserves the benefit of the doubt.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.JH
More News
7 Oct 2019 15:00

UPDATE 1-U.S. Supreme Court rejects Acorda appeal in MS drug patent fight

(Adds background to case, paragraphs 3-9)By Andrew ChungWASHINGTON, Oct 7 (Reuters) - The U.S. Supreme Court on Monday declined to hear Acorda Therapeutics Inc's appeal of a lower court ruling that allowed generic versions of its multiple sclerosi...

Read more
7 Oct 2019 14:32

U.S. Supreme Court rejects Acorda appeal in MS drug patent fight

WASHINGTON, Oct 7 (Reuters) - The U.S. Supreme Court on Monday declined to hear Acorda Therapeutics Inc's appeal of a lower court ruling that allowed generic versions of its multiple sclerosis treatment Ampyra and caused the drug's sales to plumm...

Read more
17 Sep 2019 15:02

FTSE 250 movers: Sirius plummets, Sophos climbs

(Sharecast News) - London's FTSE 250 was down 0.3% at 20,003.51 in afternoon trade on Tuesday, as Sirius Minerals led the index lower.

Read more
11 Sep 2019 07:00

RPT-GRAPHIC-FTSE 100's changing face: A trip down memory lane

(Repeats Tuesday story without changes)By Thyagaraju AdinarayanLONDON, Sept 10 (Reuters) - Marks & Spencer's exit from the FTSE 100 underlines how times have changed since the blue-chip index was launched in 1984, when it was dominated by British ...

Read more
10 Sep 2019 14:02

GRAPHIC-FTSE 100's changing face: A trip down memory lane

By Thyagaraju AdinarayanLONDON, Sept 10 (Reuters) - Marks & Spencer's exit from the FTSE 100 underlines how times have changed since the blue-chip index was launched in 1984, when it was dominated by British companies including household names lik...

Read more
4 Sep 2019 17:52

TOP NEWS: Marks & Spencer's 35 Year Spell In FTSE 100 Comes To An End

LONDON (Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 23, after completing its 100 of

Read more
4 Sep 2019 09:32

BROKER RATINGS SUMMARY: Deutsche Bank Raises BHP And Cuts Antofagasta

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:----------FTSE 100----------DEUTSCHE BANK RAISES BHP

Read more
23 Aug 2019 10:07

M&S faces FTSE 100 demotion for the first time

(Sharecast News) - Marks & Spencer is likely to drop out of the index of leading shares for the first time since the FTSE 100 was formed 35 years ago as the retailer suffers the effects of high street decline and its own problems.

Read more
13 Aug 2019 12:30

DIRECTOR DEALINGS: Hikma Pharma Finance And M&A Chiefs Sell Shares

(Alliance News) - Hikma Pharmaceuticals PLC said Tuesday its finance chief and mergers & acquisition head sold shares in the FTSE 250-listed drugmaker worth GBP2.5 million in separate on sold

Read more
9 Aug 2019 16:58

LONDON MARKET CLOSE: Mixed End Amid Weak UK Data, Trade Tension Angst

(Alliance News) - Stock prices in London closed generally lower on Friday following the release of weaker-than-forecast economic growth figures and renewed focus on tensions between the US and The

Read more
9 Aug 2019 12:23

LONDON MARKET MIDDAY: Mixed Indexes As Weak Data Crimps Upbeat WPP

(Alliance News) - Stock prices in London were mixed midday Friday following weaker-than-forecast economic growth figures, despite WPP leading a number of blue chip and mid caps on

Read more
9 Aug 2019 10:52

WINNERS & LOSERS SUMMARY: WPP Shares Surge As It Beats Forecasts

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------WPP, up a

Read more
9 Aug 2019 09:33

UPDATE: Hikma Buys Two Pipeline Products As Interim Profit Jumps

(Alliance News) - Hikma Pharmaceuticals PLC on Friday said it has acquired a manufacturing programme and two pipeline products from Insys Therapeutics Inc for an undisclosed sum.The FTSE up

Read more
9 Aug 2019 09:11

LONDON MARKET OPEN: WPP Unable To Push FTSE 100 In Green Ahead Of Data

(Alliance News) - London stocks were lacking direction early Friday as a cautious investor mood ahead of key UK economic data was offset by some positive company news.At 0930 BST, the UK releases

Read more
9 Aug 2019 08:15

Hikma Pharmaceuticals Ups Guidance As Generics Unit Lifts First Half

(Alliance News) - Hikma Pharmaceuticals PLC on Friday said profit soared in the first half of 2019, led by a strong performance from its Generics business, prompting Hikma to raise its annual FTSE

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.